281 related articles for article (PubMed ID: 5451629)
1. Mixing drugs with intravenous infusions.
Drug Ther Bull; 1970 Jul; 8(14):53-6. PubMed ID: 5451629
[No Abstract] [Full Text] [Related]
2. Drug incompatibility from the standpoint of the intravenous route of drug administration.
Williams JT
Hosp Manage; 1968 Jan; 105(1):38 passim. PubMed ID: 5634868
[No Abstract] [Full Text] [Related]
3. [Physicochemical incompatibilities of injectable drugs].
Hoffman M; Hazebroucq G
Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
[No Abstract] [Full Text] [Related]
4. [Incompatibility and other problems in adding drugs to intravenous fluids].
Hvidberg E; Bols T; Jacobsen N
Ugeskr Laeger; 1973 Jun; 135(24):1221-9. PubMed ID: 4754570
[No Abstract] [Full Text] [Related]
5. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
Outman WR; Monolakis J
Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
[No Abstract] [Full Text] [Related]
6. Incompatibilities of additives to intravenous infusion fluids.
Bourne D
Aust Nurses J; 1976 Dec-1977 Jan; 6(6-7):23, 35. PubMed ID: 1053312
[No Abstract] [Full Text] [Related]
7. [Drug incompatibilities. Problems in the simultaneous administration of drugs in infusions].
Kähny-Simonius J
Schweiz Rundsch Med Prax; 1993 Nov; 82(46):1320-7. PubMed ID: 8265949
[TBL] [Abstract][Full Text] [Related]
8. Problems of intravenous additives.
Ryan F
RANF Rev; 1977 Jan; 8(1):1, 3. PubMed ID: 585112
[No Abstract] [Full Text] [Related]
9. Parenteral incompatibilities--past, present and future.
Parker EA; Boomer RJ; Bell SC
Bull Parenter Drug Assoc; 1967; 21(6):197-207. PubMed ID: 6078886
[No Abstract] [Full Text] [Related]
10. Drug additive compatibility--a manufacturer's concern.
Nedich RL
Bull Parenter Drug Assoc; 1973; 27(5):228-33. PubMed ID: 4201030
[No Abstract] [Full Text] [Related]
11. Intravenous therapy. 7. Admixtures of drugs.
Williams JT; Moravec DF
Hosp Manage; 1966 Jul; 102(1):61-2. PubMed ID: 5938724
[No Abstract] [Full Text] [Related]
12. IV bolus: effective, but potentially hazardous (continuing education credit).
Burman R; Berkowitz HS
Crit Care Nurse; 1986; 6(1):22-8. PubMed ID: 3633789
[No Abstract] [Full Text] [Related]
13. I.v. medication compatibility chart.
Gordon EL
Crit Care Nurse; 1986; 6(4):82-3. PubMed ID: 3637148
[No Abstract] [Full Text] [Related]
14. Continuous versus intermittent intravenous antibiotics.
Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
[No Abstract] [Full Text] [Related]
15. Inadequate drug mixing: a potential hazard in continuous intravenous administration.
Gong H; King CY
Heart Lung; 1983 Sep; 12(5):528-32. PubMed ID: 6554263
[No Abstract] [Full Text] [Related]
16. Intravenous admixture incompatibility.
Donn R
Am J Nurs; 1971 Feb; 71(2):325. PubMed ID: 5203610
[No Abstract] [Full Text] [Related]
17. I.V. additives move to the pharmacy.
Peritore SP; Rosenberg JM
Hospitals; 1971 Dec; 45(24):84-91. PubMed ID: 5135288
[No Abstract] [Full Text] [Related]
18. Intravenous therapy. 6. Compatibilities of drug additives.
Williams JT; Moravec DF
Hosp Manage; 1966 Jun; 101(6):43-4. PubMed ID: 5932207
[No Abstract] [Full Text] [Related]
19. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets.
Allen LV; Levinson RS; Phisutsinthop D
Am J Hosp Pharm; 1977 Sep; 34(9):939-43. PubMed ID: 20779
[No Abstract] [Full Text] [Related]
20. Predicting pharmaceutical incompatibilities of parenteral medications.
Carlin HS; Perkins AJ
Am J Hosp Pharm; 1968 Jun; 25(6):270-9. PubMed ID: 5656772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
